Non-familial Hypercholesterolemia and Mixed Hyperlipidemia
Metabolic·MeSH: Hyperlipoproteinemia Type II
1 drug in development·1 company·1 clinical trial
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| syh2053 | NYMOX PHARMACEUTICAL CORP (NYMXF) |
Frequently asked questions
How many drugs are in development for Non-familial Hypercholesterolemia and Mixed Hyperlipidemia?
BioSniper tracks 1 drug in development for Non-familial Hypercholesterolemia and Mixed Hyperlipidemia across 1 company.
How many clinical trials target Non-familial Hypercholesterolemia and Mixed Hyperlipidemia?
There are 1 clinical trial targeting Non-familial Hypercholesterolemia and Mixed Hyperlipidemia tracked by BioSniper.
Deep-dive into Non-familial Hypercholesterolemia and Mixed Hyperlipidemia
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis